Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Mycophenolate mofetil and prednisolone for cerebral sinus venous thrombosis with Behcet's disease.

Terashita S, Tanaka T, Taneichi H, Adachi Y, Mori M.

Pediatr Int. 2019 Sep;61(9):920-922. doi: 10.1111/ped.13943. Epub 2019 Sep 11. No abstract available.

PMID:
31512337
2.

Osimertinib Administration as the Primary Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy for Brain Metastasis of De Novo T790M-positive Lung Cancer.

Noguchi S, Kawachi H, Fukao A, Terashita S, Tajiri T, Ikeue T, Horikawa S, Sugita T.

Intern Med. 2019 Oct 15;58(20):3029-3031. doi: 10.2169/internalmedicine.3169-19. Epub 2019 Jun 27.

3.

Intrapleural Urokinase Directly Under Medical Thoracoscopy for the Diagnosis of Malignant Pleural Mesothelioma With Severe Multiloculated Pleural Effusions.

Terashita S, Kawachi H, Horikawa S, Noguchi S, Ikeue T, Sugita T.

J Bronchology Interv Pulmonol. 2019 Apr;26(2):e26-e27. doi: 10.1097/LBR.0000000000000576. No abstract available.

PMID:
30908399
4.

Endobronchial Manifestation of Methotrexate-induced Lymphoproliferative Disorder.

Ikeue T, Kawachi H, Yoshida H, Tanaka E, Noguchi S, Fukao A, Terashita S, Tajiri T, Horikawa S, Sugita T.

Intern Med. 2019 Jun 1;58(11):1597-1603. doi: 10.2169/internalmedicine.2109-18. Epub 2019 Feb 1. Review.

5.

On-line sample preconcentration by polarity switching in floating electrode-integrated microchannel.

Kitagawa F, Tanigawa-Joh K, Terashita S, Fujiki R, Nukatsuka I, Sueyoshi K, Otsuka K.

Electrophoresis. 2019 Sep;40(18-19):2478-2483. doi: 10.1002/elps.201800501. Epub 2019 Jan 24.

PMID:
30637781
6.

Sarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient.

Noguchi S, Kawachi H, Yoshida H, Fukao A, Terashita S, Ikeue T, Horikawa S, Sugita T.

Case Rep Oncol. 2018 Aug 17;11(2):562-566. doi: 10.1159/000492383. eCollection 2018 May-Aug.

7.

Longitudinal study on the effectiveness of vitamin D supplements in exclusively breast-fed infants.

Terashita S, Nakamura T, Igarashi N.

Clin Pediatr Endocrinol. 2017;26(4):215-222. doi: 10.1297/cpe.26.215. Epub 2017 Sep 28.

8.

Pleuritis Caused by Mycobacterium kyorinense without Pulmonary Involvement.

Ikeue T, Yoshida H, Tanaka E, Ohi I, Noguchi S, Fukao A, Terashita S, Horikawa S, Sugita T.

Intern Med. 2017 Oct 15;56(20):2785-2790. doi: 10.2169/internalmedicine.8699-16. Epub 2017 Sep 15.

9.

Desmoplastic Small Round Cell Tumor of the Pleura Successfully Treated with a Lower Dose of Pazopanib.

Ikeue T, Ohi I, Noguchi S, Fukao A, Terashita S, Horikawa S, Sugita T.

Intern Med. 2016;55(17):2463-7. doi: 10.2169/internalmedicine.55.6395. Epub 2016 Sep 1.

10.

Comparison of intestinal metabolism of CYP3A substrates between rats and humans: application of portal-systemic concentration difference method.

Kadono K, Koakutsu A, Naritomi Y, Terashita S, Tabata K, Teramura T.

Xenobiotica. 2014 Jun;44(6):511-21. doi: 10.3109/00498254.2013.869375. Epub 2013 Dec 12.

PMID:
24329478
11.

Species differences in intestinal glucuronidation activities between humans, rats, dogs and monkeys.

Furukawa T, Naritomi Y, Tetsuka K, Nakamori F, Moriguchi H, Yamano K, Terashita S, Tabata K, Teramura T.

Xenobiotica. 2014 Mar;44(3):205-16. doi: 10.3109/00498254.2013.828362. Epub 2013 Aug 20.

PMID:
23962030
12.

Novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals.

Fujimoto K, Takemoto K, Hatano K, Nakai T, Terashita S, Matsumoto M, Eriguchi Y, Eguchi K, Shimizudani T, Sato K, Kanazawa K, Sunagawa M, Ueda Y.

Antimicrob Agents Chemother. 2013 Feb;57(2):697-707. doi: 10.1128/AAC.01051-12. Epub 2012 Nov 12.

13.

Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data.

Nakamori F, Naritomi Y, Hosoya K, Moriguchi H, Tetsuka K, Furukawa T, Kadono K, Yamano K, Terashita S, Teramura T.

Drug Metab Dispos. 2012 Sep;40(9):1771-7. doi: 10.1124/dmd.112.045476. Epub 2012 Jun 8.

PMID:
22685216
14.

Method for predicting human intestinal first-pass metabolism of UGT substrate compounds.

Furukawa T, Yamano K, Naritomi Y, Tanaka K, Terashita S, Teramura T.

Xenobiotica. 2012 Oct;42(10):980-8. doi: 10.3109/00498254.2012.680620. Epub 2012 Apr 27.

PMID:
22540538
15.

Prediction of human metabolism of FK3453 by aldehyde oxidase using chimeric mice transplanted with human or rat hepatocytes.

Sanoh S, Nozaki K, Murai H, Terashita S, Teramura T, Ohta S.

Drug Metab Dispos. 2012 Jan;40(1):76-82. doi: 10.1124/dmd.111.041954. Epub 2011 Oct 7.

PMID:
21984595
16.

Quantitative prediction of intestinal glucuronidation of drugs in rats using in vitro metabolic clearance data.

Furukawa T, Nakamori F, Tetsuka K, Naritomi Y, Moriguchi H, Yamano K, Terashita S, Teramura T.

Drug Metab Pharmacokinet. 2012;27(2):171-80. Epub 2011 Oct 4.

17.

Correlation of intrinsic in vitro and in vivo clearance for drugs metabolized by hepatic UDP-glucuronosyltransferases in rats.

Nakamori F, Naritomi Y, Furutani M, Takamura F, Miura H, Murai H, Terashita S, Teramura T.

Drug Metab Pharmacokinet. 2011;26(5):465-73. Epub 2011 Jul 5.

18.

Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.

Akabane T, Tanaka K, Irie M, Terashita S, Teramura T.

Xenobiotica. 2011 May;41(5):372-84. doi: 10.3109/00498254.2010.549970. Epub 2011 Mar 9.

PMID:
21385103
19.

[High-sensitivity C-reactive protein and changes over time in forced expiratory volume in 1 second in adult-onset asthma].

Mizumori Y, Katayama S, Igishi T, Mochiduki Y, Nakahara Y, Kawamura T, Maniwa K, Makino H, Yamamura M, Terashita S.

Nihon Kokyuki Gakkai Zasshi. 2010 Oct;48(10):719-23. Japanese.

PMID:
21066857
20.

Quantitative prediction of intestinal metabolism in humans from a simplified intestinal availability model and empirical scaling factor.

Kadono K, Akabane T, Tabata K, Gato K, Terashita S, Teramura T.

Drug Metab Dispos. 2010 Jul;38(7):1230-7. doi: 10.1124/dmd.109.029322. Epub 2010 Mar 30.

PMID:
20354105
21.

[Successful treatment of small cell lung cancer with secondary immune thrombocytopenic purpura].

Terashita S, Hirano K, Hirai T, Narabayashi T, Hara Y, Endo K, Hirabayashi M.

Nihon Kokyuki Gakkai Zasshi. 2009 Nov;47(11):1036-40. Japanese.

PMID:
19994601
22.

A comparison of pharmacokinetics between humans and monkeys.

Akabane T, Tabata K, Kadono K, Sakuda S, Terashita S, Teramura T.

Drug Metab Dispos. 2010 Feb;38(2):308-16. doi: 10.1124/dmd.109.028829. Epub 2009 Nov 12.

PMID:
19910513
23.

Exploratory population pharmacokinetics (e-PPK) analysis for predicting human PK using exploratory ADME data during early drug discovery research.

Tabata K, Hamakawa N, Sanoh S, Terashita S, Teramura T.

Eur J Drug Metab Pharmacokinet. 2009 Apr-Jun;34(2):117-28.

PMID:
19645221
24.

[A case of malignant pleural mesothelioma with gastrointestinal metastases which were diagnosed by endoscopic biopsy].

Terashita S, Hirano K, Hirai T, Narabayashi T, Hara Y, Mori H, Endo K, Hirabayashi M.

Nihon Kokyuki Gakkai Zasshi. 2009 Feb;47(2):133-8. Japanese.

PMID:
19260537
25.

Early conversion from oral morphine to transdermal fentanyl in patients with cancer pain.

Tani M, Fuku A, Terashita S, Kashiwagi H, Yukawa H, Yamaue H.

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1545-8.

PMID:
19102339
27.
28.

Strategy for structural elucidation of drugs and drug metabolites using (MS)n fragmentation in an electrospray ion trap.

Tozuka Z, Kaneko H, Shiraga T, Mitani Y, Beppu M, Terashita S, Kawamura A, Kagayama A.

J Mass Spectrom. 2003 Aug;38(8):793-808. Review.

PMID:
12938100
29.

Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro.

Naritomi Y, Terashita S, Kagayama A, Sugiyama Y.

Drug Metab Dispos. 2003 May;31(5):580-8.

PMID:
12695346
30.

Postoperative evaluation of pylorus-preserving procedures compared with conventional distal gastrectomy for early gastric cancer.

Hotta T, Taniguchi K, Kobayashi Y, Johata K, Sahara M, Naka T, Terashita S, Yokoyama S, Matsuyama K.

Surg Today. 2001;31(9):774-9.

PMID:
11686554
31.

Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans.

Naritomi Y, Terashita S, Kimura S, Suzuki A, Kagayama A, Sugiyama Y.

Drug Metab Dispos. 2001 Oct;29(10):1316-24.

PMID:
11560875
32.

Molecular cloning and functional expression of a rabbit renal organic cation transporter.

Terashita S, Dresser MJ, Zhang L, Gray AT, Yost SC, Giacomini KM.

Biochim Biophys Acta. 1998 Feb 2;1369(1):1-6.

33.

Cloning and functional expression of a human liver organic cation transporter.

Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, Giacomini KM.

Mol Pharmacol. 1997 Jun;51(6):913-21.

PMID:
9187257
34.

A species comparison of 14C-labeled 7-ethoxycoumarin metabolism in precision-cut liver slices from guinea pig and dog using a phosphor imaging system.

Terada T, Kaneko H, Terashita S, Tozuka Z, Tokuma Y, Hata T.

Res Commun Mol Pathol Pharmacol. 1996 Jan;91(1):41-56.

PMID:
8824930
35.

Sex-dependent and independent renal excretion of nilvadipine metabolites in rat: evidence for a sex-dependent active secretion in kidney.

Terashita S, Sawamoto T, Deguchi S, Tokuma Y, Hata T.

Xenobiotica. 1995 Jan;25(1):37-47.

PMID:
7604605
36.
37.

Screening for alpha-thalassemia. Correlation of hemoglobin H inclusion bodies with DNA-determined genotype.

Skogerboe KJ, West SF, Smith C, Terashita ST, LeCrone CN, Detter JC, Tait JF.

Arch Pathol Lab Med. 1992 Oct;116(10):1012-8.

PMID:
1329692
38.

Clinical evaluation of chemotherapy under angiotensin II-induced hypertension in patients with advanced cancer.

Yamaue H, Tanimura H, Terashita S, Iwahashi M, Tani M, Tsunoda T, Tamai M, Mori K.

Nihon Geka Hokan. 1990 Jul 1;59(4):302-9.

PMID:
2130794
39.

Sex differences in the metabolism and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats.

Terashita S, Tokuma Y, Sekiguchi M, Noguchi H.

Xenobiotica. 1989 Nov;19(11):1221-9.

PMID:
2618076
40.

Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.

Terashita S, Tokuma Y, Fujiwara T, Shiokawa Y, Okumura K, Noguchi H.

Xenobiotica. 1987 Dec;17(12):1415-25.

PMID:
3439192
41.

Reaction mechanism of 21S dynein ATPase from sea urchin sperm. II. Formation of reaction intermediates.

Terashita S, Kato T, Sato H, Tonomura Y.

J Biochem. 1983 Jun;93(6):1575-81.

42.

Supplemental Content

Loading ...
Support Center